Redeye provides a research update following the recently published Q3 report from Lipum. The financials in the report did not contain any major surprises. While the company’s short-term financing will need to be addressed, the highlight of Lipum’s recent period is related to its long-term financing. Last week, the company announced a take-private solution through a merger plan with majority shareholder Flerie invest.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/